Recent Updates
Recently added Catalysts
URGN Neutral Sentiment Score: 60/100

UroGen Pharma to Report First Quarter 2026 Financial Results on Wednesday, May 6th, 2026

Key Takeaway: UroGen Pharma Ltd. announced it will report its financial results for the first quarter of 2026 on May 6th, 2026, before the stock market opens. A subsequent audio webcast and conference call will take place at 10:00 AM Eastern Time. Investors will have access to a live stream and a replay for approximately 30 days. This event underscores UroGen's ongoing activities in the biotech sector.

Market Sentiment Analysis

POSITIVE FACTORS

  • UroGen Pharma is preparing to report its first quarter 2026 financial results, indicating ongoing business activity.
  • The company holds a live audio webcast for its financial results, promoting transparency and engagement with investors.

Full Press Release Details

PRINCETON, N.J., April 29, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will report first quarter 2026 financial results on Wednesday, May 6th, 2026, prior to the open of the stock market. The announcement will be followed by a live audio webcast and conference call at 10:00 AM Eastern Time.
A live public webcast of the earnings conference call can be accessed on UroGen’s Investor Relations website. Following the live webcast, a replay will be available on the site for approximately 30 days.
About UroGen Pharma Ltd.
Senior Director, Investor Relations
609-460-3588 ext. 1093
Director, Corporate Communications
609-460-3566 ext. 1083

Tags

Frequently Asked Questions

When will UroGen Pharma report its Q1 2026 financial results?

UroGen Pharma will report its Q1 2026 financial results on May 6, 2026.

What time is the UroGen earnings conference call?

The earnings conference call is scheduled for 10:00 AM Eastern Time.

How can I access the UroGen earnings webcast?

The earnings webcast can be accessed on UroGen’s Investor Relations website.

Will a replay of the UroGen conference call be available?

Yes, a replay will be available for about 30 days after the call.

Who to contact for Investor Relations at UroGen?

Contact Vincent Perrone at vincent.perrone@urogen.com or call 609-460-3588 ext. 1093.

Last updated: Apr 29, 2026